» Articles » PMID: 38539625

Morphosyntactic Abilities and Cognitive Performance in Multiple Sclerosis

Overview
Journal Brain Sci
Publisher MDPI
Date 2024 Mar 28
PMID 38539625
Authors
Affiliations
Soon will be listed here.
Abstract

While cognitive abilities in people with multiple sclerosis (PwMS) have been studied in detail, little is known about linguistic abilities in PwMS and their relation to cognitive impairment. In this cross-sectional explorative study, we aim to investigate the morphosyntactic abilities of PwMS alongside their cognitive performance. Furthermore, we explore the effect of clinical factors, namely, the disease duration and MS type, on the linguistic and cognitive performance of PwMS. By so doing, we aim to shed light on neurocognitive and clinical correlates of linguistic performance in PwMS. We included 78 patients and 78 age-, sex- and education-matched healthy individuals. All participants were additionally administered the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery, a verbal short-term memory task (non-word repetition) and questionnaires about mood, fatigue and quality of life. In addition, they underwent examinations with morphology and syntax tasks. PwMS were found to be impaired in morphology (past tense) and selectively impaired in syntax alongside cognitive impairments. Disease duration had the main impact on cognitive abilities. The MS type selectively impacted linguistic abilities, as shown by the remarkably deficient performance of the MS individuals with the progressive disease subtype. Linguistic impairments were predicted by only one measure of the BICAM test, namely, the Symbol Digit Modalities Test (SDMT), a measure of cognitive processing speed. Overall, this study contributes to the better understanding of the linguistic profile of PwMS by reporting selective deficits in their morphological and syntactical abilities. Furthermore, it provides insights into the clinical and cognitive correlates of linguistic performance. By so doing, it suggests clinical implications for the development of intervention programs for PwMS.

Citing Articles

Impact of Mast Cell Activation on Neurodegeneration: A Potential Role for Gut-Brain Axis and Infection.

Boziki M, Theotokis P, Kesidou E, Nella M, Bakirtzis C, Karafoulidou E Neurol Int. 2024; 16(6):1750-1778.

PMID: 39728753 PMC: 11677782. DOI: 10.3390/neurolint16060127.

References
1.
Velazquez-Cardoso J, Marosi-Holczberger E, Rodriguez-Agudelo Y, Yanez-Tellez G, Chavez-Oliveros M . Recall strategies for the verbal fluency test in patients with multiple sclerosis. Neurologia. 2013; 29(3):139-45. DOI: 10.1016/j.nrl.2013.03.007. View

2.
Artemiadis A, Bakirtzis C, Ifantopoulou P, Zis P, Bargiotas P, Grigoriadis N . The role of cognitive reserve in multiple sclerosis: A cross-sectional study in 526 patients. Mult Scler Relat Disord. 2020; 41:102047. DOI: 10.1016/j.msard.2020.102047. View

3.
DeLuca J, Chiaravalloti N, Sandroff B . Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat Rev Neurol. 2020; 16(6):319-332. DOI: 10.1038/s41582-020-0355-1. View

4.
Pinker S, Ullman M . The past and future of the past tense. Trends Cogn Sci. 2002; 6(11):456-463. DOI: 10.1016/s1364-6613(02)01990-3. View

5.
Kouvatsou Z, Masoura E, Kimiskidis V . Working Memory Deficits in Multiple Sclerosis: An Overview of the Findings. Front Psychol. 2022; 13:866885. PMC: 9097870. DOI: 10.3389/fpsyg.2022.866885. View